Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:MEDANTA
Clear all filters
Thyroid, antibiotic drugs face fresh safety warnings after national review
positive
ET Markets - Industry 142d ago

Thyroid, antibiotic drugs face fresh safety warnings after national review

New safety warnings are coming for two common medicines, doxycycline and carbimazole. Indian drug regulators have identified potential mental health side effects for doxycycline. Carbimazole will now carry stronger warnings about a rare but serious blood disorder. Manufacturers must update prescribing information. These changes aim to improve patient safety by highlighting important risks.

MEDANTAHealthcare
Gaudium IVF and Women Health IPO: Issue Opens For Subscription Today; Check GMP
neutral
NDTV Profit 142d ago

Gaudium IVF and Women Health IPO: Issue Opens For Subscription Today; Check GMP

The New Delhi-based fertility services provider aims to raise Rs 165 crore through its mainboard offering, which will remain open for bidding until Feb. 24.

MEDANTANDTVHealthcareMedia Entertainment & Publication
Salim Khan's Health Update: Family Requests Complete Confidentiality From Lilavati Hospital
neutral
NDTV Profit 142d ago

Salim Khan's Health Update: Family Requests Complete Confidentiality From Lilavati Hospital

Salim Khan was admitted after a brain haemorrhage

MEDANTAHealthcare
Swiggy pulls plug on Snacc as 15-minute food bet fails to scale
neutral
CNBC TV18 - Markets 142d ago

Swiggy pulls plug on Snacc as 15-minute food bet fails to scale

Swiggy shut down Snacc, its 15-minute food app which was meant to deliver home-style, unbranded meals, due to losses. Staff will move to other roles as Swiggy focuses on core services and financial health. Shares of Swiggy ended today's trade 2.3% lower at ₹326.20 on the NSE. On a YTD basis, shares have given a negative return of 16.5%.

JMFINANCILMEDANTASWIGGYConsumer ServicesFinancial Services
NEWS
neutral
Google News - Investing.com India 143d ago

Hemant Surgical Industries secures ₹264 Cr order from Ministry of Health By Trade Brains - Investing.com India

Hemant Surgical Industries secures ₹264 Cr order from Ministry of Health By Trade BrainsInvesting.com India

MEDANTAHealthcare
What do Q4 FY26 business updates tell us about banks' health?
positive
Moneycontrol NaNd ago

What do Q4 FY26 business updates tell us about banks' health?

Credit growth remains strong, while valuations look compelling after a sharp correction

MEDANTAHealthcare
Stocks to Watch Today: Maruti Suzuki, Aster DM Health, IndiaMART, RailTel Corporation, ACC, Eveready Industries, Avenue Supermarts in focus on 4 May
positive
Moneycontrol NaNd ago

Stocks to Watch Today: Maruti Suzuki, Aster DM Health, IndiaMART, RailTel Corporation, ACC, Eveready Industries, Avenue Supermarts in focus on 4 May

Stocks to Watch, 04 Apr: Stocks like Adani Enterprises, Kotak Mahindra Bank, Avenue Supermarts, ACC, Sundram Fasteners, ESAF Small Finance Bank, Capri Global Capital, Eveready Industries India, RailTel Corporation of India, IndiaMART InterMESH, Sona BLW Precision Forgings, and Aster DM Healthcare will release their quarterly earnings on April 4.

ACCADANIENTAKCAPITALPHAASTERDMAUBANKBANKINDIABANKNIFTY1CAPITALSFBCGCLCHEMICALCIFLCPCAPDMARTEQUITASBNKESAFSFBEVEREADYFOCUSGLOBALHCGHCG-REHEALTHCAREINDIAMARTINDOSTARJSFBKOTAKBANKLIQUID1LTFMARUTIMEDANTAMID150M&MMMFLMNCMOMENTUM30MSCIINDIANEXT50ETFNIFTY100EWPRECISIONPSUBANKQUALITY30RAILTELSILVER1SONACOMSSUNDRMFASTSURYODAYUJJIVANSFBUTKARSHBNKAutomobile and Auto ComponentsConstruction Materials
Buy Star Health and Allied Insurance; target of Rs 644: ICICI Securities
positive
Moneycontrol NaNd ago

Buy Star Health and Allied Insurance; target of Rs 644: ICICI Securities

ICICI Securities is bullish on Star Health and Allied Insurance has recommended buy rating on the stock with a target price of Rs 644 in its research report dated May 03, 2026.

ICICIGIICICIPRULIMEDANTANIVABUPASTARSTARHEALTHFinancial ServicesHealthcare
Buy Star Health; target of Rs 650: Emkay Global Financial
positive
Moneycontrol NaNd ago

Buy Star Health; target of Rs 650: Emkay Global Financial

Emkay Global Financial is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 650 in its research report dated April 29, 2026.

EMKAYGLOBALJMFINANCILMEDANTASTARSTARHEALTHConsumer ServicesFinancial Services
Buy Star Health; target of Rs 640: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Star Health; target of Rs 640: Motilal Oswal

Motilal Oswal is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 640 in its research report dated April 29, 2026.

MEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARSTARHEALTHFinancial ServicesHealthcare
Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal

Motilal Oswal recommended is bullish on Niva Bupa Health Insurance recommended buy rating on the stock with a target price of Rs 100 in its research report dated Jun 19, 2026.

MEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENIVABUPASTARHEALTHFinancial ServicesHealthcare
Vijaya Diagnostic Centre: Excellent health report in Q4 FY26
positive
Moneycontrol NaNd ago

Vijaya Diagnostic Centre: Excellent health report in Q4 FY26

This diagnostics player is well-positioned to compound earnings

EXCELLENTMEDANTAVIJAYACapital GoodsHealthcare